Optimizing Diabetes Mellitus Care As a Key to Prevent Severe COVID-19

  • Luse Loe Department of Internal Medicine, Faculty of Medicine and Health Science Atma Jaya Catholic University of Indonesia, Jakarta
  • Ferius Soewito Flexfree Musculoskeletal Rehabilitation Clinic
Keywords: COVID-19 severity, diabetes mellitus, diabetes management

Abstract

Coronavirus disease 2019 (COVID-19) is one of the leading health problems globally, including in Indonesia. The first case of COVID-19 in Indonesia was discovered on March 2nd 2020. From then until August 7th 2022, 6.244.978 cases of COVID-19 and 157.095 COVID-19-related death have been recorded. A high virus transmission rate, various clinical manifestations, morbidity and mortality caused by COVID-19 alerts clinician to notice some factors which can make a person vulnerable to COVID-19 and which factors contribute to severe COVID-19. Indonesia’s COVID-19 case fatality rate (CFR) is higher than the global CFR. COVID-19 mortality in Indonesia mainly occurs in patients with comorbidity, of which the most common is diabetes mellitus.

Downloads

Download data is not yet available.

Author Biography

Luse Loe, Department of Internal Medicine, Faculty of Medicine and Health Science Atma Jaya Catholic University of Indonesia, Jakarta

Endocrinology, Metabolic and Diabetes Division, Internal Medicine Department, Faculty of Medicine Padjajaran University – Dr. Hasan Sadikin Central General Hospital Bandung, Indonesia

Published
2022-08-30
How to Cite
Loe, L., & Soewito, F. (2022). Optimizing Diabetes Mellitus Care As a Key to Prevent Severe COVID-19. Journal Of The Indonesian Medical Association, 72(3), 105 - 108. https://doi.org/10.47830/jinma-vol.72.3-2022-840